General Information of Drug Off-Target (DOT) (ID: OTPAMQ18)

DOT Name Regulator of G-protein signaling 13 (RGS13)
Synonyms RGS13
Gene Name RGS13
Related Disease
Pediatric lymphoma ( )
Mantle cell lymphoma ( )
Non-insulin dependent diabetes ( )
Adult lymphoma ( )
Burkitt lymphoma ( )
Lymphoma ( )
UniProt ID
RGS13_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00615
Sequence
MSRRNCWICKMCRDESKRPPSNLTLEEVLQWAQSFENLMATKYGPVVYAAYLKMEHSDEN
IQFWMACETYKKIASRWSRISRAKKLYKIYIQPQSPREINIDSSTRETIIRNIQEPTETC
FEEAQKIVYMHMERDSYPRFLKSEMYQKLLKTMQSNNSF
Function Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Binds to both G(i)-alpha and G(q)-alpha.
Reactome Pathway
G alpha (i) signalling events (R-HSA-418594 )
G alpha (q) signalling events (R-HSA-416476 )

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Pediatric lymphoma DIS51BK2 Definitive Altered Expression [1]
Mantle cell lymphoma DISFREOV Strong Biomarker [2]
Non-insulin dependent diabetes DISK1O5Z Strong Genetic Variation [3]
Adult lymphoma DISK8IZR Disputed Altered Expression [1]
Burkitt lymphoma DIS9D5XU Disputed Altered Expression [1]
Lymphoma DISN6V4S Disputed Altered Expression [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Regulator of G-protein signaling 13 (RGS13). [4]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Regulator of G-protein signaling 13 (RGS13). [5]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Regulator of G-protein signaling 13 (RGS13). [6]
Estradiol DMUNTE3 Approved Estradiol affects the expression of Regulator of G-protein signaling 13 (RGS13). [7]
Triclosan DMZUR4N Approved Triclosan increases the expression of Regulator of G-protein signaling 13 (RGS13). [8]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Regulator of G-protein signaling 13 (RGS13). [9]
Fluorouracil DMUM7HZ Approved Fluorouracil decreases the expression of Regulator of G-protein signaling 13 (RGS13). [10]
Niclosamide DMJAGXQ Approved Niclosamide decreases the expression of Regulator of G-protein signaling 13 (RGS13). [11]
Cytarabine DMZD5QR Approved Cytarabine decreases the expression of Regulator of G-protein signaling 13 (RGS13). [12]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Regulator of G-protein signaling 13 (RGS13). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Regulator of G-protein signaling 13 (RGS13). [13]
------------------------------------------------------------------------------------

References

1 RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization.J Leukoc Biol. 2006 Jun;79(6):1357-68. doi: 10.1189/jlb.1105693. Epub 2006 Mar 24.
2 High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.Leukemia. 2003 Sep;17(9):1880-90. doi: 10.1038/sj.leu.2403057.
3 A genome-wide association study implicates that the TTC39C gene is associated with diabetic maculopathy with decreased visual acuity.Ophthalmic Genet. 2019 Jun;40(3):252-258. doi: 10.1080/13816810.2019.1633549. Epub 2019 Jul 2.
4 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
5 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
6 Gamma-irradiation and doxorubicin treatment of normal human cells cause cell cycle arrest via different pathways. Mol Cells. 2005 Dec 31;20(3):331-8.
7 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72. doi: 10.1091/mbc.e03-06-0360. Epub 2003 Dec 29.
8 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
9 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
10 Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells. Int J Gynecol Cancer. 2006 May-Jun;16(3):1321-9.
11 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
12 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
13 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
14 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.